We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC, Calif. Launch Reverse Payment Challenge

Law360 (February 2, 2009, 12:00 AM EST) -- In yet another challenge to reverse payment settlements, the state of California and the Federal Trade Commission have filed a lawsuit against several pharmaceutical companies, claiming their patent lawsuit settlements over the testosterone supplement AndroGel violate U.S. antitrust laws.

The lawsuit filed in the U.S. District Court for the Central District of California and announced by the FTC on Monday alleges that settlements Watson Pharmaceuticals Inc., Par Pharmaceutical Cos. Inc. and Paddock Laboratories reached with Solvay Pharmaceuticals Inc. that included agreements not to market generic versions...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.